Buscar





Buscar





Mercado
/
Acciones
/
nasdaq-iqv
/

IQVIA Holdings Inc

IQV

Añadir a la lista de seguimiento

178.710USD

+0.160+0.09%

Cierre 05/08, 16:00（ET）Cotizaciones retrasadas 15 min

29.83BCap. mercado

22.00P/E TTM



IQVIA Holdings Inc

178.710

+0.160+0.09%

Descripción general Finanzas Análisis Compañía

Descripción general

Finanzas

Análisis

Compañía

Más Datos de IQVIA Holdings Inc Compañía

IQVIA Holdings Inc. is a global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. Its segments include Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides mission-critical information, technology solutions and real-world insights and services to the Company’s life science clients. The Research & Development Solutions segment primarily serves biopharmaceutical customers, and provides outsourced clinical research and clinical trial-related services. The Contract Sales & Medical Solutions segment provides healthcare provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the broader healthcare market. It offers a set of strategic and implementation consulting services, including advanced analytics and commercial processes outsourcing services.

Información de IQVIA Holdings Inc



Símbolo de cotizaciónIQV

Nombre de la empresaIQVIA Holdings Inc

Fecha de salida a bolsaMay 09, 2013

Director ejecutivoBousbib (Ari)

Número de empleados88000

Tipo de seguridadOrdinary Share

Fin del año fiscalMay 09

Dirección2400 Ellis Road

CiudadDURHAM

Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE

PaísUnited States of America

Código postal27703

Teléfono19199982000

Sitio Webhttps://ir.iqvia.com/

Símbolo de cotizaciónIQV

Fecha de salida a bolsaMay 09, 2013

Director ejecutivoBousbib (Ari)

Ejecutivos de IQVIA Holdings Inc



Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Ari Bousbib

Chairman of the Board, Chief Executive Officer

1.41M

+2.04%

Mr. Ronald E. (Ron) Bruehlman

Chief Financial Officer, Executive Vice President

65.53K

+14.55%

Mr. Eric M. Sherbet

Executive Vice President, General Counsel, Secretary

30.89K

+15.83%

Mr. John G. Danhakl

Independent Director

30.32K

+5.25%

Dr. John M. Leonard, M.D.

Lead Independent Director

16.95K

+9.27%

Ms. Colleen A. Goggins

Independent Director

14.45K

+10.87%

Ms. Carol J. Burt

Independent Director

5.96K

Mr. Bhavik Patel

President, Commercial Solutions

3.03K

+71.48%

Mr. James A. Fasano

Independent Director

1.06K

Mr. John P. Connaughton

Independent Director

1.05K

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Ari Bousbib

Chairman of the Board, Chief Executive Officer

1.41M

+2.04%

Mr. Ronald E. (Ron) Bruehlman

Chief Financial Officer, Executive Vice President

65.53K

+14.55%

Mr. Eric M. Sherbet

Executive Vice President, General Counsel, Secretary

30.89K

+15.83%

Mr. John G. Danhakl

Independent Director

30.32K

+5.25%

Dr. John M. Leonard, M.D.

Lead Independent Director

16.95K

+9.27%

Ms. Colleen A. Goggins

Independent Director

14.45K

+10.87%

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de abr

FY2025

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

La empresa aún no ha revelado los datos relevantes.

Por regiónUSD

Nombre

Ganancia

Proporción

Americas

7.75B

47.49%

Europe & Africa Region

5.18B

31.79%

Asia Pacific Region

3.38B

20.72%

Por negocio

Por región

La empresa aún no ha revelado los datos relevantes.

Estadísticas de accionistas

Actualizado: dom., 10 de may

Accionistas

Tipos de accionistas

Accionistas

Proporción

Harris Associates L.P.

6.78%

Vanguard Capital Management, LLC

6.61%

BlackRock Institutional Trust Company, N.A.

5.19%

Vanguard Portfolio Management, LLC

4.54%

State Street Investment Management (US)

4.46%

Otro

72.42%

Accionistas

Proporción

Harris Associates L.P.

6.78%

Vanguard Capital Management, LLC

6.61%

BlackRock Institutional Trust Company, N.A.

5.19%

Vanguard Portfolio Management, LLC

4.54%

State Street Investment Management (US)

4.46%

Otro

72.42%

Tipos de accionistas

Accionistas

Proporción

Investment Advisor

48.99%

Investment Advisor/Hedge Fund

38.83%

Sovereign Wealth Fund

5.32%

Hedge Fund

2.94%

Pension Fund

2.82%

Research Firm

2.77%

Bank and Trust

2.23%

Individual Investor

1.00%

Family Office

0.16%

Participación institucional



Actualizado: dom., 5 de abr

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2026Q1

2209

173.06M

103.69%

-9.60M

2025Q4

2132

171.19M

100.94%

-15.17M

2025Q3

2061

175.98M

103.33%

-829.63K

2025Q2

2053

166.70M

98.05%

-9.45M

2025Q1

2083

168.53M

97.38%

-9.36M

2024Q4

2059

171.87M

97.45%

+3.00M

2024Q3

2008

173.01M

95.44%

+863.78K

2024Q2

1977

164.85M

90.43%

-7.68M

2024Q1

1950

165.50M

90.84%

-10.38M

2023Q4

1948

168.90M

93.03%

-6.38M

Actividad de los accionistas



Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

Harris Associates L.P.

11.32M

6.74%

-67.55K

-0.59%

Dec 31, 2025

BlackRock Institutional Trust Company, N.A.

8.67M

5.16%

-772.77K

-8.18%

Dec 31, 2025

State Street Investment Management (US)

7.45M

4.44%

-102.01K

-1.35%

Dec 31, 2025

GIC Private Limited

6.54M

3.9%

-2.59M

-28.36%

Mar 31, 2025

Geode Capital Management, L.L.C.

4.37M

2.61%

+24.45K

+0.56%

Dec 31, 2025

Boston Partners

4.09M

2.43%

+530.67K

+14.92%

Dec 31, 2025

Artisan Partners Limited Partnership

3.37M

2.01%

-62.57K

-1.82%

Dec 31, 2025

AllianceBernstein L.P.

3.30M

1.97%

-293.54K

-8.16%

Dec 31, 2025

ETFs relacionados



Actualizado: mar., 2 de dic

Nombre

Proporción

First Trust Nasdaq Lux Digi Health Solutions ETF

9.1%

Langar Global HealthTech ETF

7.83%

Global X HealthTech ETF

5.5%

VanEck Biotech ETF

4.98%

iShares Biotechnology ETF

3.23%

iShares Health Innovation Active ETF

3.05%

Adaptive Core ETF

3.04%

Invesco Bloomberg Pricing Power ETF

2.24%

Running Oak Efficient Growth ETF

2.16%

Invesco Zacks Mid-Cap ETF

2.08%

First Trust Nasdaq Lux Digi Health Solutions ETF

Proporción9.1%

Langar Global HealthTech ETF

Proporción7.83%

Global X HealthTech ETF

Proporción5.5%

VanEck Biotech ETF

Proporción4.98%

iShares Biotechnology ETF

Proporción3.23%

iShares Health Innovation Active ETF

Proporción3.05%

Adaptive Core ETF

Proporción3.04%

Invesco Bloomberg Pricing Power ETF

Proporción2.24%

Running Oak Efficient Growth ETF

Proporción2.16%

Invesco Zacks Mid-Cap ETF

Proporción2.08%

Dividendos



Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Sin datos

División de acciones



Fecha

Fecha ex-dividendo

Tipo

Relación

Sin datos

Fecha

Fecha ex-dividendo

Tipo

Relación

Sin datos

KeyAI

